Switch to
More onapp

How to use scorecard? Learn more

Dr. Lal PathLabs Ltd

LALPATHLAB
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹21,854 cr, stock is ranked 291
Moderate RiskStock is 2.87x as volatile as Nifty
2,626.2045.00 (+1.74%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹21,854 cr, stock is ranked 291
Moderate RiskStock is 2.87x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
61.10
PB RatioPB Ratio
12.86
Dividend YieldDiv. Yield
0.92%
Sector PESector PE
42.13
Sector PBSector PB
5.98
Sector Div YldSctr Div Yld
0.64%

Forecast & RatingsDetailed Forecast 

55%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Dr Lal Pathlabs Private Limited is headquartered in Gurgaon, Haryana, India and is a medical laboratory operator.

Brands

Dr. Lal PathLabs

Diagnostic and healthcare services by Dr. Lal PathLabs Ltd

Investor PresentationView older 

Aug 8, 2023

PDF
View Older Presentations

Brands

Dr. Lal PathLabs

Diagnostic and healthcare services by Dr. Lal PathLabs Ltd

Financial TrendFinancial statements 

20212022202320241.632.142.062.300.290.340.240.36
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Investor Presentation 
Announced OnMay 20, 2024

Dr. Lal Path Labs Ltd. has informed the Exchange about Investor Presentation | Download

Dr. Lal Path Labs Ltd. has informed the Exchange about Investor Presentation | Download

Alteration Of Capital and Fund Raising-XBRL 
Announced OnMay 10, 2024

DR. LAL PATH LABS LTD. has informed the Exchange regarding Allotment of Securities | Download

DR. LAL PATH LABS LTD. has informed the Exchange regarding Allotment of Securities | Download

Cash Dividend 
Ex. DateFeb 13, 2024

Interim 2 • Div/Share: ₹ 12

See all events